QuickView for transcription elongation from RNA polymerase II promoter (biogroup)

1. Neural development of iPSCs derived from Autistic patients with BCKD-kinase mutations
2. Lung adenocarcinoma and adjacent normal tissue miRNA expression profiles
3. Calu-3 lung adenocarcinoma cells infected with wildtype and mutant SARS virus
4. L1000 CMAP - Neural progenitor NPC.CAS9 cells treated with small molecule perturbagens
5. Follicular fluid miRNA profiles during the development of the oocyte

There were no matches for transcription elongation from RNA polymerase II promoter

There were no clinical trials for transcription elongation from RNA polymerase II promoter